Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy
| Autor: | Milena Peruhova, Monika Peshevska-Sekulovska, Gabriela Panayotova, Tsvetelina Velikova |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Gastroenterology Insights, Vol 12, Iss 3, Pp 283-292 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2036-7422 2036-7414 |
| DOI: | 10.3390/gastroent12030025 |
| Popis: | In liver transplant patients, solid tumors and post-transplant lymphoproliferative disorders (PTLD) have emerged as significant long-term mortality causes. Additionally, it is assumed that de novo malignancy (DNM) after liver transplantation (LT) is the second-leading cause of death after cardiovascular complications. Well-established risk factors for PTLD and solid tumors are calcineurin inhibitors (CNIs), tacrolimus (TAC), and cyclosporine, the cornerstones of all immunosuppressive (IS) therapies used after LT. The loss of immunocompetence facilitated by the host immune system due to prolonged IS therapy leads to cancer development, including in LT patients. Hindering DNA repair mechanisms, promoting tumor cell invasiveness, and hampering apoptosis are critical events in tumorigenesis and tumor growth in LT patients resulting from IS administration. This paper aims to overview the refined mechanisms of IS-induced tumorigenesis after LT and the loss of immunocompetence facilitated by the host immune system due to prolonged IS therapy. In addition, we also discuss in detail the mechanisms of action in different types of IS regimen used after LT, and their putative effect on DNM. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|